Astellas Pharma Inc. Logo

Astellas Pharma Inc.

A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.

4503 | T

Overview

Corporate Details

ISIN(s):
JP3942400007
LEI:
Country:
Japan
Address:
中央区日本橋本町二丁目5番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Astellas Pharma Inc. is a global pharmaceutical company dedicated to improving human health by turning innovative science into value for patients. Formed in 2005 from the merger of Yamanouchi Pharmaceutical Co. and Fujisawa Pharmaceutical Co., the company engages in the research, development, manufacturing, and marketing of innovative pharmaceutical products. Astellas focuses on addressing unmet medical needs in several therapeutic areas, with a primary emphasis on oncology. Its key areas of innovation also include gene therapy, immuno-oncology, regenerative medicine, and treatments for blindness and mitochondrial diseases. The company is committed to a stable supply of reliable medicines worldwide and stands at the forefront of healthcare change.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 03:29
Report Publication Announcement
確認書
Japanese 8.9 KB
2025-11-06 03:26
Interim Report
半期報告書-第21期(2025/04/01-2026/03/31)
Japanese 310.0 KB
2025-07-31 08:30
Registration Form
訂正発行登録書
Japanese 9.7 KB
2025-07-31 04:04
Post-Annual General Meeting Information
訂正臨時報告書
Japanese 33.0 KB
2025-07-03 08:31
Registration Form
訂正発行登録書
Japanese 10.3 KB
2025-07-02 02:28
Post-Annual General Meeting Information
臨時報告書
Japanese 24.1 KB
2025-06-16 06:14
Governance Information
内部統制報告書-第20期(2024/04/01-2025/03/31)
Japanese 23.1 KB
2025-06-16 06:11
Registration Form
確認書
Japanese 8.7 KB
2025-06-16 06:09
Annual Report
有価証券報告書-第20期(2024/04/01-2025/03/31)
Japanese 2.5 MB
2025-02-04 07:47
Registration Form
訂正発行登録書
Japanese 9.9 KB
2025-02-04 07:40
Regulatory News Service
臨時報告書
Japanese 19.4 KB
2025-02-04 07:39
Regulatory News Service
臨時報告書
Japanese 20.9 KB
2024-11-06 05:52
Interim Report
確認書
Japanese 8.9 KB
2024-11-06 05:51
Interim Report
半期報告書-第20期(2024/04/01-2025/03/31)
Japanese 344.2 KB
2024-09-03 03:34
Registration Form
発行登録追補書類(株券、社債券等)
Japanese 96.0 KB

Automate Your Workflow. Get a real-time feed of all Astellas Pharma Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Astellas Pharma Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Astellas Pharma Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MiNK Therapeutics, Inc. Logo
Developing allogeneic iNKT cell therapies for cancer and immune-mediated diseases.
United States of America
INKT
MIRA PHARMACEUTICALS, INC. Logo
Develops novel ketamine and THC analogs for neurologic and neuropsychiatric disorders.
United States of America
MIRA
Mirum Pharmaceuticals, Inc. Logo
Develops and commercializes therapies for rare, debilitating liver diseases in children and adults.
United States of America
MIRM
Mithra Pharmaceuticals S.A. Logo
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
Belgium
MITRA
MIZUHO MEDY CO.,LTD. Logo
Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.
Japan
4595
MOA Life Plus Co. Ltd. Logo
Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.
South Korea
142760
Moberg Pharma Logo
Develops & commercializes a leading topical treatment for nail fungus for European markets.
Sweden
MOB
Mochida Pharmaceutical Co.,Ltd. Logo
An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.
Japan
4534
Moderna, Inc. Logo
Pioneering mRNA science to create transformative medicines and vaccines for diverse diseases.
United States of America
MRNA
Monopar Therapeutics Logo
Clinical-stage biotech developing radiopharmaceuticals for oncology and therapies for rare diseases.
United States of America
MNPR

Talk to a Data Expert

Have a question? We'll get back to you promptly.